September 21, 2021

Biotalys to Participate in Upcoming Investor and Stakeholder Events

September 17, 2021

Biotalys Reports Half-Year 2021 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
September 17, 2021

Biotalys Board and Executive Changes

PDF icon
EN PDF icon
NL
September 9, 2021

Biotalys Officially Opens New Headquarters and Research Facilities in Ghent

PDF icon
EN PDF icon
NL
September 3, 2021

Biotalys announces end of Stabilization Period and the partial exercise of the Over-allotment Option in respect of 712,942 Shares in connection with its Initial Public Offering

August 24, 2021

Biotalys Notice of Half Year 2021 Results

PDF icon
EN
August 3, 2021

Total number of voting rights and shares

PDF icon
EN PDF icon
NL
August 2, 2021

Biotalys announces end of Stabilization Period and the partial exercise of the Over-allotment Option in respect of 712,942 Shares in connection with its Initial Public Offering

PDF icon
EN PDF icon
NL
July 15, 2021

Publication of transparency notifications

PDF icon
EN PDF icon
NL
July 6, 2021

Biotalys Appoints Markus Heldt as Independent Director

PDF icon
EN PDF icon
NL
July 6, 2021

Information on the total number of voting rights and shares

July 5, 2021

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
July 1, 2021

Biotalys announces successful €54.6 million Initial Public Offering

PDF icon
EN PDF icon
FR PDF icon
NL
July 1, 2021

Biotalys announces successful €54.6 million Initial Public Offering

July 1, 2021

Biotalys Announces Expected Successful Closing of its Initial Public Offering

Subscribe to our news